university website

M.J. Hoogduijn (Martin), F. Popp (Felix), A.U. Grohnert (Anja), M.J. Crop (Meindert), M. van Rhijn (Marieke), A.T. Rowshani (Ajda), E. Eggenhofer (Elke), P. Renner (Philipp), M.E. Reinders (Marlies), T.J. Rabelink (Ton), et al. L.J.W. van der Laan (Luc), F.J.M.F. Dor (Frank), J.N.M. IJzermans (Jan), P.G. Genever (Paul), C.M. Lange (Claudia), A. Durrbach (Antoine), H.J. Houtgraaf (Jaco), B. Christ (Bruno), M. Seifert (Martina), M. Shagidulin (Murat), V. Donckier (Vincent), R. Deans (Robert), O. Ringden (Olle), N. Perico (Norberto), G. Remuzzi (Giuseppe), A. Bartholomew (Amelia), H.J. Schlitt (Hans), W. Weimar (Willem), C.C. Baan (Carla) and M.H. Dahlke (Marc)

2010-07-27

Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT)

Publication

Publication

Transplantation , Volume 90 - Issue 2 p. 124- 126

There is evolving interest in the use of mesenchymal stem cells (MSC) in solid organ transplantation. Pre-clinical transplantation models show efficacy of MSC in prolonging graft survival and a number of clinical studies are planned or underway. At a recent meeting of the MISOT consortium (MSC In Solid Organ Transplantation) the advances of these studies were evaluated and mechanisms underlying the potential effects of MSC discussed. Continued discussion is required for definition of safety and eventually efficacy endpoints for MSC therapy in solid organ transplantation.

Additional Metadata
Keywords Clinical trial, MISOT, Mesenchymal stem cell, Solid organ transplantation
Persistent URL doi.org/10.1097/TP.0b013e3181ea4240, hdl.handle.net/1765/27295
Journal Transplantation
Organisation Erasmus MC: University Medical Center Rotterdam
Citation
Hoogduijn, M., Popp, F., Grohnert, A., Crop, M., van Rhijn, M., Rowshani, A., … Dahlke, M. (2010). Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation, 90(2), 124–126. doi:10.1097/TP.0b013e3181ea4240


User Publication Person Organisation Collection
Close